Subclinical hypothyroidism is a mild form of hypothyroidism where thyroid hormone levels are within the normal range, but thyroid-stimulating hormone (TSH) levels are slightly elevated.
Ranked by community outcomes, then evidence grade, Health Voice mentions, and recency.
Why it may help Subclinical Hypothyroidism: Often low; supports thyroid
Why it may help Subclinical Hypothyroidism: Co-factor for thyroid hormone
Ginseng is a traditional adaptogenic herb, primarily from the Panax genus, commonly used for energy, cognitive support, and stress adaptation, though scientific evidence for many uses is still emerging.
Why it may help Subclinical Hypothyroidism: Reduces thyroid inflammation
Why it may help Subclinical Hypothyroidism: Reduces antibodies and improves conversion
Why it may help Subclinical Hypothyroidism: Iodine is a crucial component of thyroid hormones, and its supplementation can support thyroid hormone production in individuals with subclinical hypothyroidism due to iodine deficiency.
Why it may help Subclinical Hypothyroidism: Iron is a critical cofactor for thyroid peroxidase, an enzyme necessary for thyroid hormone synthesis, and its supplementation can improve thyroid function in individuals with subclinical hypothyroidism and iron deficiency.
Why it may help Subclinical Hypothyroidism: Modestly raises TSH-normal thyroid
Why it may help Subclinical Hypothyroidism: Whole-food selenium
Why it may help Subclinical Hypothyroidism: Corrects iodine insufficiency
Active B12 form essential for nerve function and red blood cell production.
Why it may help Subclinical Hypothyroidism: L-Tyrosine is a precursor to thyroid hormones, and its supplementation may support the synthesis of these hormones, potentially benefiting individuals with subclinical hypothyroidism.
Why it may help Subclinical Hypothyroidism: Magnesium is essential for the conversion of thyroid hormones and can improve thyroid function by reducing inflammation and supporting the body's response to thyroid-stimulating hormone in subclinical hypothyroidism.
Omega-3 fatty acids are essential polyunsaturated fats, primarily EPA and DHA, that may influence inflammatory and immune pathways, with ongoing research into their potential health applications.
Bladderwrack is a brown seaweed rich in iodine, traditionally used for thyroid support, but its high iodine content necessitates cautious use, especially for individuals with thyroid conditions.
Community outcomes
Self-reported by community members · not medical advice.
Self-reported community outcomes. Not medical advice. Requires at least three reports per remedy to surface.
Community outcome data is still being collected for this ailment.
Be the first to share your experience →As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.
Structured experience reports from people managing this condition. Not medical advice.
You can share without an account — we'll send a one-time code to verify your email. Or sign in.
Loading posts…
Community Discussions
How global health authorities view Subclinical Hypothyroidism.
Major international health bodies generally recommend a watchful waiting approach for subclinical hypothyroidism, especially for mild elevations in TSH. The American Thyroid Association (ATA) and European Thyroid Association (ETA) guidelines suggest considering treatment for TSH levels above 10 mIU/L, or for TSH levels between 4.0-10.0 mIU/L in symptomatic individuals, pregnant women, or those with specific risk factors. The role of nutritional supplements and herbal remedies in the management of subclinical hypothyroidism is not widely endorsed by these bodies due to a lack of robust clinical trial data, though some acknowledge the importance of adequate micronutrient status for overall thyroid health.
Indexed studies for Subclinical Hypothyroidism, grouped by source type and quality.
Filter by source type
Pooled analyses across multiple human trials.
Osinga JAJ, Nelson SM, Walsh JP, Ashoor G, Palomaki GE, López-Bermejo A · The Journal of clinical endocrinology and metabolism · 2024 · n=496
Establishing local trimester-specific reference intervals for gestational TSH and free T4 (FT4) is often not feasible, necessitating alternative strategies. We aimed to systematically quantify the diagnostic performance of standardized modifications of center-specific nonpregnancy reference intervals as compared to trimester-specific reference intervals. We included prospective cohorts participating in the Consortium on Thyroid and Pregnancy. After relevant exclusions, reference intervals were calculated per cohort in thyroperoxidase antibody-negative women. Modifications to the nonpregnancy reference intervals included an absolute modification (per .1 mU/L TSH or 1 pmol/L free T4), relative modification (in steps of 5%) and fixed limits (upper TSH limit between 3.0 and 4.5 mU/L and lower FT4 limit 5-15 pmol/L). We compared (sub)clinical hypothyroidism prevalence, sensitivity, and positive predictive value (PPV) of these methodologies with population-based trimester-spec
Holley M, Razvi S, Farooq MS, Dew R, Maxwell I, Wilkes S · Systematic reviews · 2024 · n=3853
Thyroid dysfunction is common in older people, with females at higher risk. Evidence suggests that thyroid-stimulating hormone (TSH) levels naturally increase with age. However, as uniform serum TSH reference ranges are applied across the adult lifespan, subclinical hypothyroidism (SCH) diagnosis is more likely in older people, with some individuals also being commenced treatment with levothyroxine (LT4). It is unclear whether LT4 treatment in older people with SCH is associated with adverse cardiovascular or bone health outcomes. A systematic review and meta-analysis were performed to synthesise previous studies evaluating cardiovascular and bone health outcomes in older people with SCH, comparing LT4 treatment with no treatment. PubMed, Embase, Cochrane Library, MEDLINE, and Web of Science databases were searched from inception until March 13, 2023, and studies that evaluated cardiovascular and bone health events in people with SCH over 50 years old were selected. Six articles that
Vitamin B12 levels in thyroid disorders: A systematic review and meta-analysis.
Benites-Zapata VA, Ignacio-Cconchoy FL, Ulloque-Badaracco JR, Hernandez-Bustamante EA, Alarcón-Braga EA, Al-Kassab-Córdova A · Frontiers in endocrinology · 2023 · n=28597
Numerous studies have found an association between vitamin deficiency and thyroid disorders (TD). The presence of anti-parietal cell antibodies is indicative of reduced ability to absorb vitamin B12. Thus, this study reviewed the existing studies with the objective of assessing differences in the serum levels of vitamin B12 among patients with and without TD, the frequency of vitamin B12 deficiency in patients with TD, and the presence of anti-parietal cell antibodies in patients with TD. A meta-analysis of random-effects model was conducted to calculate pooled frequencies, mean differences (MD), and their respective 95% confidence intervals (CI). We identified 64 studies that met our inclusion criteria (n = 28597). We found that patients with hypothyroidism had lower vitamin B12 levels than healthy participants (MD: -60.67 pg/mL; 95% CI: -107.31 to -14.03 pg/mL; p = 0.01). No significant differences in vitamin B12 levels were observed between healthy participants and patients with h
Structured reviews of the full body of evidence (incl. Cochrane).
Alwan H, Villoz F, Feller M, Dullaart RPF, Bakker SJL, Peeters RP · European journal of endocrinology · 2022 · n=178
Few prospective studies have assessed whether individuals with subclinical thyroid dysfunction are more likely to develop diabetes, with conflicting results. In this study, we conducted a systematic review of the literature and an individual participant data analysis of multiple prospective cohorts to investigate the association between subclinical thyroid dysfunction and incident diabetes. We performed a systematic review of the literature in Medline, Embase, and the Cochrane Library from inception to February 11, 2022. A two-stage individual participant data analysis was conducted to compare participants with subclinical hypothyroidism and subclinical hyperthyroidism vs euthyroidism at baseline and the adjusted risk of developing diabetes at follow-up. Among 61 178 adults from 18 studies, 49% were females, mean age was 58 years, and mean follow-up time was 8.2 years. At the last available follow-up, there was no association between subclinical hypothyroidism and incidence of diabet
Recommendations from medical societies (NICE, AHA, ADA, ACG, Endocrine Society…).
Janett-Pellegri C, Moutzouri E, Darbellay Farhoumand P, Rodondi N, Agoritsas T · Revue medicale suisse · 2020
Subclinical hypothyroidism is frequent and its treatment by thyroid hormones is debated. Current guidelines tend to recommend a treatment for symptomatic adults or for thyrotropin (TSH) levels > 10 mIU/l. Nevertheless, new evidence from systematic review, -including 21 trials and 2192 participants, demonstrated that thyroid hormone replacement has no clinically relevant benefit on patients' symptoms or prognosis. An international and independent panel -including physicians, methodologists and patients issues a strong recommendation (BMJ Rapid Recommendation) against thyroid hormones therapy for adults with subclinical hypothyroidism. This recommendation does not apply to women who are pregnant or trying to conceive or to patients with TSH > 20 mIU/l. L’hypothyroïdie infraclinique est une entité fréquente et les bénéfices d’un traitement de substitution hormonal sont peu clairs. Les diverses guidelines recommandent actuellement
Subclinical hypothyroidism in the infertile female population: a guideline.
Practice Committee of the American Society for Reproductive Medicine · Fertility and sterility · 2015
There is controversy regarding whether to treat subtle abnormalities of thyroid dysfunction in the infertile female patient. This guideline document reviews the risks and benefits of treating subclinical hypothyroidism in female patients with a history of infertility and miscarriage, as well as obstetrical and neonatal outcomes in this population.
Clinical practice guidelines for the management of hypothyroidism.
Brenta G, Vaisman M, Sgarbi JA, Bergoglio LM, Andrada NC, Bravo PP · Arquivos brasileiros de endocrinologia e metabologia · 2013
Hypothyroidism has long been known for its effects on different organ systems, leading to hypometabolism. However, subclinical hypothyroidism, its most prevalent form, has been recently related to cardiovascular risk and also to maternal-fetal complications in pregnant women. In these clinical practice guidelines, several aspects of this field have been discussed with the clear objectives of helping physicians treat patients with hypothyroidism, and of sharing some of our Latin American-based clinical experience. The Latin American Thyroid Society commissioned a Task Force on Hypothyroidism to develop evidence-based clinical guidelines on hypothyroidism. A systematic review of the available literature, focused on the primary databases of MedLine/PubMed and Lilacs/SciELO was performed. Filters to assess methodological quality were applied to select the best quality studies. The strength of recommendation on a scale from A-D was based on the Oxford Centre for Evidence--based Medicine,
Controlled human studies with random assignment.
Metaverse Clinic for Pregnant Women With Subclinical Hypothyroidism: Prospective Randomized Study.
Zheng Y, Chen Y, Chen Y, Lin L, Xue T, Chen C · Journal of medical Internet research · 2025 · n=30
Health care is experiencing new opportunities in the emerging digital landscape. The metaverse, a shared virtual space, integrates technologies such as augmented reality, virtual reality, blockchain, and artificial intelligence. It allows users to interact with immersive digital worlds, connect with others, and explore unknowns. While the metaverse is gaining traction across various medical disciplines, its application in thyroid diseases remains unexplored. Subclinical hypothyroidism (SCH) is the most common thyroid disorder during pregnancy and is frequently associated with adverse pregnancy outcomes. This study aims to evaluate the safety and effectiveness of a metaverse platform in managing SCH during pregnancy. A randomized controlled trial was conducted at Fujian Provincial Hospital, China, from July 2022 to December 2023. A total of 60 pregnant women diagnosed with SCH were randomly assigned into two groups: the standard group (n=30) and the metaverse group (n=30). Both groups
Netzer S, Chocano-Bedoya P, Feller M, Janett-Pellegri C, Wildisen L, Büchi AE · Age and ageing · 2023 · n=267
loss of skeletal muscle function, strength and mass is common in older adults, with important socioeconomic impacts. Subclinical hypothyroidism is common with increasing age and has been associated with reduced muscle strength. Yet, no randomized placebo-controlled trial (RCT) has investigated whether treatment of subclinical hypothyroidism affects muscle function and mass. this is an ancillary study within two RCTs conducted among adults aged ≥65 years with persistent subclinical hypothyroidism (thyrotropin (TSH) 4.60-19.99 mIU/l, normal free thyroxine). Participants received daily levothyroxine with TSH-guided dose adjustment or placebo and mock titration. Primary outcome was gait speed at final visit (median 18 months). Secondary outcomes were handgrip strength at 1-year follow-up and yearly change in muscle mass. we included 267 participants from Switzerland and the Netherlands. Mean age was 77.5 years (range 65.1-97.1), 129 (48.3%) were women, and their mean baseline
Cohort, case-control, and cross-sectional human studies.
Vitamin D Status and Its Association With Disease Severity in Hashimoto's Thyroiditis.
Copari-Vargas E, Copari-Vargas TL, Domínguez-Valdez LF, Copari-Vargas LE, Copari-Jimenez E · Cureus · 2025 · n=21
Introduction Hashimoto's thyroiditis (HT), the most common autoimmune thyroid disorder, involves chronic lymphocytic infiltration and thyroid dysfunction. Vitamin D deficiency has been linked to autoimmune thyroid diseases, suggesting an immunomodulatory role. This study examines the association between serum vitamin D levels and HT severity in patients at a secondary-level hospital in Mexico. Methods A retrospective observational study was conducted on adult patients diagnosed with HT from January 2022 to January 2024. Clinical and laboratory data, including serum 25-hydroxyvitamin D (25(OH)D), thyroid-stimulating hormone (TSH), free thyroxine (FT4), and anti-thyroid peroxidase (anti-TPO) antibodies, were collected. Patients were classified by thyroid function and vitamin D status. Statistical analyses were performed to evaluate correlations and group associations to determine the relationship between vitamin D deficiency and HT severity. Results A total of 114 patients were included
Fatemeh A, Elham ZY, Kosar CZ, Homeira R, Maryam M · Medicine · 2025 · n=106
Subclinical hypothyroidism (SCH) is biochemically characterized by elevated thyrotropin (thyroid-stimulating hormone [TSH]) levels, while free thyroxine (FT4) levels remain normal. Given the high prevalence of vitamin D deficiency in Iran, investigating the association between vitamin D levels and SCH may improve treatment. A case-control study was conducted at the endocrinology clinic of Imam Khomeini Hospital, affiliated with Ahvaz Jundishapur University of Medical Sciences. A total of 106 subjects who met the inclusion criteria were selected and divided into 2 groups: 53 subjects with SCH and 53 healthy controls (HC). Serum levels of vitamin D, TSH, and FT4 were obtained from medical records. Other variables including age, weight, and height were also recorded. Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 26. The mean age of the SCH and HC groups was 35.98 ± 12.9 years and 34.34 ± 13.49
Considerations in the Diagnosis and Management of Thyroid Dysfunction in Older Adults.
Jasim S, Papaleontiou M · Thyroid : official journal of the American Thyroid Association · 2025
Background: Thyroid dysfunction is common in older adults and poses diagnostic and management challenges for clinicians. In this narrative review, we present published data focusing on special considerations in the diagnosis and management of hypothyroidism and hyperthyroidism in older adults. Methods: A comprehensive literature search of the PubMed and Ovid MEDLINE databases was conducted from January 2000 to December 2024 to identify pertinent articles in English for this narrative review. Results: Due to significant cardiovascular risk if untreated, both overt hypothyroidism and hyperthyroidism should be treated in older adults. Findings from observational studies do not support treating older adults with subclinical hypothyroidism with a thyrotropin (TSH) <7 mIU/L. However, observational data have demonstrated an increased risk of cardiovascular mortality and stroke in older adults with subclinical hypothyroidism with TSH 7.0-9.9 mIU/L and of coronary heart disease, cardiovascul
Registered ongoing or completed trials (ClinicalTrials.gov).
n=900 · NCT07257250 · RECRUITING · RECRUITING
Subclinical hypothyroidism (SCH) is defined by elevated thyroid-stimulating hormone (TSH) with normal free thyroxine (fT4) levels. It affects approximately 5-7% of women of reproductive age and may negatively influence outcomes of assisted reproductive technology (ART). During controlled ovarian stimulation, rising estradiol increases thyroxine-binding globulin and thyroid hormone requirements. These physiological changes, combined with increased metabolic demand in early pregnancy, may worsen SCH and contribute to adverse outcomes such as miscarriage, preterm birth, and hypertensive disorders of pregnancy. Although levothyroxine (LT4) is routinely used to treat overt hypothyroidism, evidence for its benefit in SCH, especially among infertile women undergoing In Vitro Fertilization (IVF) or Intra-Cytoplasmic Sperm Injection (ICSI) with frozen embryo transfer (FET), remains inconclusive. Some trials and meta-analyses have shown reductions in miscarriage and neonatal mortality, while others have found no improvement in ART or obstetric outcomes. This study aims to evaluate the effectiveness of levothyroxine therapy on IVF/FET outcomes and subsequent pregnancy results in women with subclinical hypothyroidism and infertility. This retrospective cohort study will emulate the target trial to evaluate whether LT4 treatment, titrated to achieve a pre-transfer TSH \< 2.5 mIU/L, improves implantation, live birth, and obstetric outcomes compared with expectant management.
n=96 · NCT04249271 · COMPLETED · COMPLETED
One prospective observational study was carried out in 2009 aiming at identifying the fluctuations of the thyroid hormones in women with normal thyroid gland and in women with anti-TPO antibodies. Serum samples were collected periodically during and after pregnancy in previously infertile women. The samples were stored frozen at -80 °C. Now, the hormone measurements will be carried out.
n=184 · NCT02832934 · COMPLETED · COMPLETED
Coronary heart disease (CHD) are the leading causes of mortality and morbidity, particularly with the current context of an aging population. Prospective cohort studies, as well as analyses of pooled individual participant data suggest up to a 60-90% increase in the risk of CHD or HF events among adults with severe SHypo. However, no large randomized controlled trials (RCT) have assessed the impact of thyroid replacement on cardiovascular (CV) imaging outcomes. The goals of this proposal are to address the impact of thyroid replacement on subclinical atherosclerosis. The investigators will conduct a RCT in 185 patients with subclinical hypothyroidism who will be randomly assigned to thyroxine or placebo with an average follow-up of 24 months from baseline. The main outcome will be CV imaging modalities measured by carotid ultrasound at the close-out visit. Assessment of the impact of thyroid replacement on subclinical atherosclerosis within a trial will aid decisions and evidence-based guidelines development to treat a potential modifiable risk factor, such as SHypo.
Conventional medical care for subclinical hypothyroidism typically involves monitoring TSH levels over time. Treatment with levothyroxine (synthetic thyroid hormone) may be considered for individuals with TSH levels consistently above 10 mIU/L, or for those with TSH levels between 4.0-10.0 mIU/L who are symptomatic, pregnant, or have other risk factors like positive thyroid antibodies. The decisio
Latest News
Health Videos
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any decisions about your health or treatment, especially if you have a diagnosed medical condition or are taking medications.
Found something that helped your subclinical hypothyroidism?
Help others see what actually works.
Found something that helped your subclinical hypothyroidism?
Real-world results help others choose what's worth trying.